StockpollyBeta
Get App
Delisting riskPopularity #4,028
AMIX · NASDAQ · Medical - Devices

Autonomix Medical (AMIX)

Develops transvascular catheters to sense, target, and ablate peripheral nerves.

$4.20
After hours+0.04 (+0.96%)
At close$4.16(+2.72%)

In millions of USD, except per-share figures

In millionsQ2 FY24Sep 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Cost of revenue000000000000
Gross profit000000000000
632333338333
Research & development011111222212
122222225211
General & administrative122222225211
Other expenses500000000000
Operating income−6−3−2−3−3−3−3−3−8−3−3−3
00−3000000000
Interest income000000000000
Interest expense000000000000
Other non-operating income003000000000
Income before tax−6−3−5−3−3−3−3−3−7−3−3−3
Net income from continuing operations−6−3−5−3−3−3−3−3−7−3−3−3
Net income−6−3−5−3−3−3−3−3−7−3−3−3
EPS, basic−$134.98−$64.47−$120.52−$59.97−$51.82−$30.75−$26.84−$22.57−$28.91−$7.65−$4.91−$5.02
EPS, diluted−$134.98−$64.47−$120.52−$59.97−$51.82−$30.75−$26.84−$22.57−$28.91−$7.65−$4.91−$5.02
Weighted average shares, basic000000000011
Weighted average shares, diluted000000000011
EBITDA−6−3−5−3−3−3−3−3−7−3−3−3
Depreciation & amortization000000000000
EBIT−6−3−5−3−3−3−3−3−7−3−3−3